We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

53 hedge funds and large institutions have $139M invested in TriSalus Life Sciences in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 3

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

20% more funds holding

Funds holding: 44 → 53 (+9)

11% more capital invested

Capital invested by funds: $125M → $139M (+$13.6M)

5.85% more ownership

Funds ownership: 51.77% → 57.62% (+5.8%)

Holders
53
Holders Change
+9
Holders Change %
+20.45%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
15
Reduced
3
Closed
3
Calls
$63K
Puts
–
Net Calls
+$63K
Net Calls Change
+$63K

Top Buyers

Rank Fund Capital Flow
1
VI
Vestcor Inc
New Brunswick, Canada
+$2.29M
2
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$2.21M
3
MA
MYDA Advisors
New York
+$1.96M
4
JGC
J. Goldman & Co
New York
+$1.83M
5
SV
Starboard Value
New York
+$1.47M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.37M
2
MP
Mangrove Partners
Connecticut
-$966K
3
WRBC
W.R. Berkley Corp
Connecticut
-$240K
4
Morgan Stanley
Morgan Stanley
New York
-$1.23K
5
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$26.7M – – –
PWAM
2
Park West Asset Management
California
$12.1M – – –
AC
3
Aristeia Capital
Connecticut
$11.2M – – –
Marshall Wace
4
Marshall Wace
United Kingdom
$7.96M +$980K +100,000 +14%
LA
5
Linden Advisors
New York
$7.09M – – –
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$6.55M – – –
Citadel Advisors
7
Citadel Advisors
Florida
$5.49M +$12.5K +1,279 +0.2%
SCC
8
Spring Creek Capital
Kansas
$4.88M – – –
RCM
9
Radcliffe Capital Management
Pennsylvania
$4.02M – – –
MA
10
MYDA Advisors
New York
$3.91M +$1.96M +200,000 +98%
Tudor Investment Corp
11
Tudor Investment Corp
Connecticut
$3.89M – – –
Verition Fund Management
12
Verition Fund Management
Connecticut
$3.02M +$7.54K +769 +0.2%
HSBC Holdings
13
HSBC Holdings
United Kingdom
$2.94M – – –
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$2.8M – – –
VI
15
Vestcor Inc
New Brunswick, Canada
$2.69M +$2.29M +233,772 +553%
CH
16
CVI Holdings
Delaware
$2.42M – – –
SCM
17
Shaolin Capital Management
Florida
$2.42M – – –
PMAM
18
Picton Mahoney Asset Management
Ontario, Canada
$2.18M +$2.21M +224,997 New
OPU
19
Omni Partners US
California
$2.14M +$2.17M +220,971 New
Wellington Management Group
20
Wellington Management Group
Massachusetts
$2.1M -$1.37M -139,305 -39%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$1.94M – – –
JGC
22
J. Goldman & Co
New York
$1.81M +$1.83M +187,020 New
AGC
23
Angelo Gordon & Co
New York
$1.76M – – –
CCM
24
Context Capital Management
California
$1.69M – – –
Goldman Sachs
25
Goldman Sachs
New York
$1.68M +$147K +14,980 +9%
1
2 3

TLSI Hedge Fund Activity: Q2 2021 in Review

53 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q2 2021, worth a combined $139M — up 11% from $125M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TLSI positions and 3 closed out — a net gain of 10 holders — while 15 added to existing stakes and 3 trimmed.

The largest buyer was Vestcor Inc, adding an estimated $2.29M. The largest seller was Wellington Management Group, cutting an estimated $1.37M.

  • 53 institutional investors held TriSalus Life Sciences (TLSI) as of Q2 2021, up from 44 in Q1 2021.
  • Funds reported $139M of TriSalus Life Sciences stock for Q2 2021, up 11% quarter-over-quarter.
  • 13 funds opened new TriSalus Life Sciences positions in Q2 2021 and 3 closed out, a net change of +10 holders.
  • The largest TriSalus Life Sciences buyer in Q2 2021 was Vestcor Inc, an estimated $2.29M added.
  • The largest TriSalus Life Sciences seller in Q2 2021 was Wellington Management Group, an estimated $1.37M sold.

Based on aggregated 13F filings for Q2 2021.